Baker Brothers Life Sciences LP's Net Worth
$0
Who is Baker Brothers Life Sciences LP?
Baker Brothers Life Sciences LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Seagen Inc., BeiGene, Ltd., INCYTE CORP, Prelude Therapeutics Inc, XOMA Corp, Kiniksa Pharmaceuticals, Ltd., Zymeworks Inc., IGM Biosciences, Inc., Kodiak Sciences Inc., ACADIA PHARMACEUTICALS INC, IDERA PHARMACEUTICALS, INC., DBV Technologies S.A., TScan Therapeutics, Inc., Neurogene Inc., Aeglea BioTherapeutics, Inc., Talis Biomedical Corp, ALEXION PHARMACEUTICALS INC, MADRIGAL PHARMACEUTICALS, INC., SYNAGEVA BIOPHARMA CORP, GENOMIC HEALTH INC, Mirati Therapeutics, Inc., BIOCRYST PHARMACEUTICALS INC, vTv Therapeutics Inc., Kymera Therapeutics, Inc., BICYCLE THERAPEUTICS PLC, and Immunocore Holdings plc.
SEC CIK
Baker Brothers Life Sciences LP's CIK is 0001363364
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BeiGene, Ltd. (BGNE) Snapshot price: $191.32
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +34.99% | 65.36K |
—
|
—
| 252.19K |
Jun 5
| |||
Form 4
| -9.43% | -1.10M |
$180.50 | -$198,550,000.00 | 10.57M |
Nov 14
| |||
Form 4
| +38.25% | 51.69K |
—
|
—
| 186.83K |
Jun 15
| |||
Form 4
| +97.65% | 66.77K |
—
|
—
| 135.14K |
Jun 22
| |||
Form 4
| +83.93% | 31.2K |
—
|
—
| 68.37K |
Jun 16
| |||
Form 4
| -1.03% | -121.15K |
$220.50 | -$26,714,457.00 | 11.67M |
Jan 4
| |||
Form 4
| -11.53% | -1.54M |
$220.50 | -$333,295,893.00 | 11.81M |
Oct 13 - Dec 4
| |||
Form 4
| +276.32% | 14.58M |
$14.23 | $207,544,548.74 | 19.86M |
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| -35.69% | -651.49K |
—
|
—
| 1.17M |
Jun 5 - Jun 6
| |||
Form 4
| +15,636.87% | 5.81M |
$108.00 | $627,922,800.00 | 5.85M |
Aug 2
| |||
Form 4
| +0.05% | 37.16K |
—
|
—
| 79.73M |
Jun 6
| |||
Form 4
| +51.44% | 1.98M |
$101.00 | $199,999,998.00 | 5.83M |
Jan 18
| |||
Form 4
| -71.13% | -35.00K |
—
|
—
| 14.2K |
Oct 13
| |||
Form 4
| +4.79% | 176.06K |
$71.00 | $12,499,976.00 | 3.85M |
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 19
| |||
Form 4
| +92.04% | 1.76M |
$32.00 | $56,335,840.00 | 3.67M |
Nov 18
| |||
Form 4
| +64.92% | 82.25M |
$10.01 | $47,654,320.28 | 208.94M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prelude Therapeutics Inc (PRLD) Snapshot price: $5.18
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
| +0.10% | 10.38K |
$12.85 | $133,331.60 | 10.13M |
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
| +49.15% | 9.91M |
$19.00 | $29,999,993.00 | 30.08M |
Mar 27 - Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kiniksa Pharmaceuticals, Ltd. (KNSA) Snapshot price: $24.93
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.45% | 12.69K |
—
|
—
| 2.85M |
Jun 5
| |||
Form 4
| +0.62% | 17.49K |
—
|
—
| 2.84M |
Jun 6
| |||
Form 4
| +0.71% | 20K |
—
|
—
| 2.82M |
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
| -57.03% | -170.74K |
—
|
—
| 128.66K |
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
∞
| 3M |
$18.00 | $54,000,000.00 | 3M |
Feb 9 - May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zymeworks Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IGM Biosciences, Inc. (IGMS) Snapshot price: $10.17
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.10% | 3.99K |
—
|
—
| 4.11M |
Jun 28
| |||
Form 4
| +0.10% | 3.99K |
—
|
—
| 4.1M |
Mar 29
| |||
Form 4
| +2.52% | 395.32K |
$9.09 | $3,425,568.67 | 16.07M |
Mar 26 - Mar 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
| +0.03% | 1.11K |
—
|
—
| 3.71M |
Dec 29
| |||
Form 4
| +2.67% | 532.69K |
$6.26 | $3,431,463.82 | 20.45M |
Dec 13 - Dec 15
| |||
Form 4
| +0.03% | 1.11K |
—
|
—
| 3.17M |
Sep 29
| |||
Form 4
| +0.03% | 1.11K |
—
|
—
| 3.17M |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 4
| |||
Form 4
| +0.03% | 1.11K |
—
|
—
| 3.17M |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
| +0.36% | 22.42K |
$28.14 | $641,853.82 | 6.32M |
Jan 27
| |||
Form 4
| +0.01% | 446 |
—
|
—
| 3.15M |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
| +0.01% | 446 |
—
|
—
| 3.15M |
Oct 1
| |||
Form 4
| +0.01% | 446 |
—
|
—
| 3.14M |
Jul 1
| |||
Form 4
| +0.01% | 446 |
—
|
—
| 3.14M |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
|
∞
| 3.14M |
$16.00 | $50,304,000.00 | 3.14M |
Sep 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||